Shenzhen Bingchuan Network (300533.SZ) issues a forecasted loss, expecting a loss of 240 million to 340 million yuan in 2024, turning from a profit to a loss year-on-year.
Glacier Network (300533.SZ) released its 2024 annual performance forecast, expecting 2024 net profit attributable to listed...
Shenzhen Bingchuan Network (300533.SZ) released its annual performance forecast for 2024, expecting a net loss attributable to shareholders of the listed company of 240 million to 340 million yuan in 2024, a year-on-year change from profit to loss.
During the reporting period, the company significantly increased its investment in overseas markets and new online products, with a focus on games such as "Hero Clash," "Epic War," "Titan War," "Kingdom Go!," "Love in the Air," and "Merge Topia," resulting in increased sales expenses and operating costs.
During the reporting period, due to significantly higher overseas market traffic costs, the company's overseas market recovery period is longer compared to the domestic product recovery period. In addition, games like "X-hero," "Super World," and "Hero Clash" have had their revenue recognition period extended due to the prolongation of their lifecycle.
As of December 31, 2024, the company's non-recurring gains and losses for the reporting period amounted to approximately 63 million yuan, mainly from government subsidies and deposit investment income.
Related Articles

US Stock Market Move | Autodesk, Inc. (ADSK.US) rebounds more than 5% after falling nearly 11% in the previous three trading days.

US Stock Market Move | Quantum computing sector rose, Quantum Computing (QUBT.US) surged over 5%

US Stock Market Move | Sonnet BioTherapeutic (SONN.US) soared by over 110%, with stock prices nearly increasing 8 times within the month.
US Stock Market Move | Autodesk, Inc. (ADSK.US) rebounds more than 5% after falling nearly 11% in the previous three trading days.

US Stock Market Move | Quantum computing sector rose, Quantum Computing (QUBT.US) surged over 5%

US Stock Market Move | Sonnet BioTherapeutic (SONN.US) soared by over 110%, with stock prices nearly increasing 8 times within the month.

RECOMMEND

Rare Sales Decline for Tank Brand—How Will Great Wall Motor Defend Its Market Position?
14/07/2025

Inside the Explosive Growth of the New Tea Beverage Sector: Supply Chains, Innovation, and Cultural Capital
14/07/2025

Hafu Securities Joins the Race as Hong Kong Accelerates Its Push to Become a Virtual Asset Hub
14/07/2025